Search - tctmd.com

Displaying 1 - 20 of 37

Sort: Relevancy | Date

News Daily News

Even With Optimized GDMT, HFrEF Prognosis Remains Dire

Michael O'Riordan

January 30, 2026

News Daily News

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

Michael O'Riordan

December 30, 2025

News Daily News

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Michael O'Riordan

May 07, 2024

News Daily News

STRONG-HF: Higher GDMT Doses Equal Better Outcomes

Todd Neale

December 29, 2023

News Daily News

Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes

Michael O'Riordan

June 23, 2023

News Daily News

HFrEF’s Financial Burden May Get Relief From Inflation Reduction Act

L.A. McKeown

January 13, 2023

News Daily News

Dapagliflozin Safe, Effective in Diabetes Regardless of Background CV Meds

Shelley Wood

July 25, 2022

News Daily News

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

Michael O'Riordan

July 11, 2022

News Daily News

Uptick in ‘Implausible’ Cancers Reported After ARB Recalls

L.A. McKeown

August 20, 2021

News Daily News

Continue ACE Inhibitors/ARBs in COVID-19, New Study Confirms

Michael O'Riordan

April 02, 2021

News Daily News

HF Care Gaps May Stem From Patient-Specific Factors, Canadian Study Finds

Michael O'Riordan

August 13, 2020

News Daily News

Risk of Dying Doubled in Wuhan COVID-19 Patients With Hypertension

L.A. McKeown

June 08, 2020

News Daily News

No Worse COVID-19 Prognosis With ACE Inhibitors, ARBs: ‘Living’ Review Suggests

Yael L. Maxwell

May 21, 2020

News Daily News

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

Michael O'Riordan

May 05, 2020

News Daily News

ACE Inhibitors, ARBs, and COVID-19: New Insights, Advice

Yael L. Maxwell

March 26, 2020

News Daily News

COVID-19 Should Not Guide Use of ACE Inhibitors/ARBs, Heart Societies Say

Todd Neale

March 17, 2020

News Daily News

Type 2 MI Linked to More CV Deaths, Even in Younger Patients

Shelley Wood

March 04, 2020

News Daily News

Nighttime Hypertension Drug Dosing May Reduce Risk of CVD

L.A. McKeown

October 23, 2019

News Daily News

ARB Use Linked to Suicide in New Study, but Is the Finding Real?

Michael O'Riordan

October 18, 2019

News Daily News

Recurrent Events Common Among Young Patients With CAD

Michael O'Riordan

October 11, 2019

Advertisement

Even With Optimized GDMT, HFrEF Prognosis Remains Dire

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

STRONG-HF: Higher GDMT Doses Equal Better Outcomes

Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes

HFrEF’s Financial Burden May Get Relief From Inflation Reduction Act

Dapagliflozin Safe, Effective in Diabetes Regardless of Background CV Meds

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

Uptick in ‘Implausible’ Cancers Reported After ARB Recalls

Continue ACE Inhibitors/ARBs in COVID-19, New Study Confirms

HF Care Gaps May Stem From Patient-Specific Factors, Canadian Study Finds

Risk of Dying Doubled in Wuhan COVID-19 Patients With Hypertension

No Worse COVID-19 Prognosis With ACE Inhibitors, ARBs: ‘Living’ Review Suggests

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

ACE Inhibitors, ARBs, and COVID-19: New Insights, Advice

COVID-19 Should Not Guide Use of ACE Inhibitors/ARBs, Heart Societies Say

Type 2 MI Linked to More CV Deaths, Even in Younger Patients

Nighttime Hypertension Drug Dosing May Reduce Risk of CVD

ARB Use Linked to Suicide in New Study, but Is the Finding Real?

Recurrent Events Common Among Young Patients With CAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content